Clinical trials found substantial weight loss and improved cardiovascular outcomes associated with taking these medications
The FDA signed off on Eli Lillys Zepbound for moderatetosevere obstructive sleep apnea in adults with obesity after results from the SURMOUNTOSA studies, according to an FDA news release
Each dose bump deepens appetite suppression, further reducing calorie intake and intensifying that tired-at-the-gym feeling
Tirzepatide Maintenance Dose After Weight Loss The recommended tirzepatide doses for maintenance of weight loss are 5 mg, 10 mg, or 15 mg weekly, depending on a persons response
What is the difference between Ozempic and semaglutide
The JPML found that NAION cases share common factual questions involving: Drug development and clinical testing Marketing and promotional practices Labeling and warning decisions Regulatory history and FDA interactions Scientific evidence linking GLP-1 drugs to optic nerve injury Because the medical mechanisms, risk profiles, and damages associated with permanent vision loss differ significantly from those of gastrointestinal claims, the court concluded that combining them would be inefficient and potentially unfair to plaintiffs